Volume: 17

1. Changes in Carotid Intima-media Thickness and Left Ventricular Mass by Control of Blood Pressure and Hyperlipidemia in Hypertensive Patients. Page:177—184
2. Relationship between Clinical Factors Including Physical Activity and Job Category and Masked Effect Defined by Ambulatory Blood Pressure Monitoring. Page:166—176
3. Association of Hypertension and Obesity with Echocardiographic Left Ventricular Hypertrophy or Microalbuminuria in a General Population in South Korea. Page:156—165
4. Current Controversies over the Management of Elderly Hypertension with Impaired Renal Function. Page:148—155
5. Cyclophilin A: A Mediator of Cardiovascular Pathology. Page:133—147
6. Influence of Metabolic Syndrome on Hypertension-related Target Organ Damage: Diagnosis of Metabolic Syndrome Is Still Necessary. Page:125—132
7. Age effects on the differences between Omron HEM 907 blood pressure monitor and manual mercury sphygmomanometer blood pressure readings. Page:114—124
8. The Phase 4 Randomized, Public, Parallel, Comparative, Clinical Trial to Compare Efficacy and Safety of S-(-)-Amlodipine Nicotinate with Ramipril in Hypertensive Patients. Page:103—113
9. The Preventive and Therapeutic Effects of Aronox Extract on Metabolic Abnormality and Hypertension. Page:95—102
10. Antihypertensive Therapy Considering the Prevention of Vascular Aging. Page:85—94
11. Ambient Particulate Matter and the Risk of Deaths from Cardiovascular and Cerebrovascular Disease. Page:74—83
12. Association between Alcohol Consumption and Hypertension. Page:65—73
13. Expression of Lectin like Oxidized Low Density Lipoprotein Receptor-1 in the Spontaneous Hypertensive Rat with High Cholesterol Diet. Page:57—64
14. Imatinib Mesylate Attenuates Cardiac Fibrosis in Spontaneously Hypertensive Rats. Page:48—56
15. Transient Receptor Potential Vanilloid Type-1 Channel in Cardiometabolic Protection. Page:37—47
16. Effects of Bosentan Treatment on Angiotensin Converting Enzyme in Monocrotaline Induced Pulmonary Hypertension Rats. Page:28—36
17. Effects of Angiotensin II and Shear Stress Interaction on Vascular Inflammation. Page:17—27
18. How Much Do We Lower the Blood Pressure in Hypertensive Patients with Diabetes?. Page:10—16
19. The Appropriate Interpretation of Recent Clinical Trials: How to Read RCT in the Era of Advertizing-based Medicine. Page:1—9